Current Pharmaceutical Biotechnology
Rituximab:
The First Monoclonal Antibody Approved for the Treatment of
Lymphoma
A.J.
Grillo-López, C.A. White, B.K. Dallaire, C.L. Varns, C.D. Shen, A. Wei,
J.E. Leonard,
A. McClure, R. Weaver, S. Cairelli and
J. Rosenberg
Use
of Recombinant Human Erythropoietin as an Antianemic and Performance
Enhancing Drug
W.
Jelkmann
Growth Velocity, Final Height
and Bone Mineral Metabolism
of
Roberto
Lanes
Advances
in Biotechnology for Tissue Engineering of Bone
U.
Ripamonti and
J.R Tasker
Transcription
Factors as Potential Targets for Therapeutic Drugs
David
S. Latchman
Modulation
of Metabolism Through Transcriptional Control has created New Treatment
Opportunities for Type 2 Diabetes
Esper
Boel, Tatjana Albrektsen, Jan Fleckner and Johan Selmer
The
Chick Embryo Chorioallantoic Membrane as a Model for in vivo
Research on Anti-Angiogenesis
Domenico
Ribatti, Angelo Vacca, Luisa Roncali and
Franco Dammacco
Toward
The Rational Design of Cell Fate Modifiers: Notch Signaling as a Target
for Novel Biopharmaceuticals
A.
Zlobin, M. Jang and L. Miele
Inhibition
of Cellular Proliferation by Drug Targeting of Cyclin-Dependent
Kinases
Ignacio
Pérez-Roger, Carmen Ivorra, Antonio Díez, María José Cortés,
Enric
Poch, Silvia M. Sanz-González and
Vicente Andrés
